Cresence

Cresence AS, a company established in 2020 by a group of researchers and pharmaceutical development professionals, is dedicated to the advancement of innovative technologies and revolutionary treatments for unmet medical requirements and rare diseases. Our focus involves enhancing the value of molecules to create novel neuroprotective medications through a comprehensive research and development strategy. Additionally, we strive to optimize the effectiveness of orphan drugs for specific niche uses, supported by substantial scientific evidence.